Marco Pappagallo, M.D.
- Clinical Professor, Department of Anesthesiology
Location
- 60 Gramercy Park N. 1A New York, NY 10010
Research Profiles
Professional Interests
CURRICULUM VITAE
MARCO PAPPAGALLO, M.D.
Department of Pain Medicine and Palliative Care
Tel 212-844-6410 / 212-844-8932 Fax 212-844-6414
UPIN E66149
EDUCATION
1976 - 1982 School of Medicine,
POST-GRADUATE TRAINING
1982 - 1986 Post-doctoral Training, Neurosurgery Institute of Neurosurgery, Univ. of Rome, Italy 1986 - 1987 Internship, Internal Medicine Cabrini Medical Ctr., NY Medical College, NY 1987 - 1990 Residency, Neurology State University of New York at Stony Brook, NY 1990 - 1993 Clinical & Research Fellowship in Pain Medicine The Johns Hopkins Pain Treatment Center, Baltimore, MD
ACADEMIC APPOINTMENTS
1993 - 1995 Clinical Instructor Departments of Neurology, Neurosurgery, Anesthesia & Critical Care Medicine The
1995 - 1999 Assistant Professor Departments of Neurology, Neurosurgery, Anesthesia & CCM The Johns Hopkins Univ. School of Medicine, Baltimore, MD 1999 - 2003 Associate Professor Dept. of Neurology - NYU School of Medicine, New York, NY
2003 - Present. Associate Professor Dept. of Neurology and Dept. of Anesthesiology and CCM;
HOSPITAL and AFFILIATED INSTITUTION APPOINTMENTS
1995 - 1999 Director Division of Pain Medicine, Department of Neurology The Johns Hopkins Medical Institutions Baltimore, MD Attending Physician The Johns Hopkins Hospital, Baltimore, MD 1999 - 2003 Director Comprehensive Pain Treatment Center Hospital for Joint Diseases, Mt. Sinai/NYU Health, New York, NY Attending Physician Hospital for Joint Diseases and NYU Hospitals, New York, NY 2003 ¡V present Director Division of Chronic Pain, Department of Pain Medicine and Palliative Care Beth Israel Medical Center, New York, NY Attending Physician Beth Israel Medical Center, New York, NY
BOARD CERTIFICATIONS
1992 ABPN Board Certification # 36631 in Neurology
2000 ABMS Board Certification #29 in Pain Management Recognized by the American Board of Psychiatry and Neurology (ABPN), the American Board of Anesthesiology (ABA), and the American Board of Physical Medicine and Rehabilitation (ABPMR)
PROFESSIONAL SOCIETY MEMBERSHIP
1988 - present
NATIONAL AND INTERNATIONAL ACTIVITIES, EDUCATIONAL AND ADMINISTRATIVE COMMITTEES, INVITED EDITORIAL ACTIVITIES, AWARDS AND HONORS
1994 APS Scientific Program Committee and Specialty Subcommittees
1994 - 1999 The
1994 - 1999 Back Pain Association of
1996 - 1999 The Pain Medicine Journal Club Journal, Expert Analyst
1997 - 1998 The Journal of Acute Pain and Symptom Management, Member
1998 Consumer Reports on Health, Consultant 1998 Union Institute Graduate College, Consultant
1995-1999 AAN International Pain Section, Chairperson
1998 Dannemiller Memorial Educational Foundation
1998-1999 American
1999 Imaging Neurogenic Inflammation in Patients with Migraine Headaches, Scientific Topic Highlights Plenary Session, AAN 51st Meeting,
2000 Merck unrestricted educational grant, Recipient
2000 Wyeth-Ayerst unrestricted educational grant, Recipient
2000 Ortho-McNeal unrestricted educational grant, Recipient
2000 - 2003 HJD, Pharmacy and Therapeutics Committee
1999 - Present ad hoc reviewer for The Lancet, The Clinical Journal of Pain, The Journal of Pain and Symptom Management, The Journal of Pharmaceutical Sciences, NIDCR / NIH, Analgesia, The Journal of Pain, Pain
2000 - Present Current Pain and Headache Reports, Editorial Board, Member
2000 - Present Pain Practice, Editorial Board, Member 2001 Education and Research in Pain and Palliative Care at
2000 - 2002 American
2001 ABPN oral exams,
2001-2002 NIH Pain and Palliative Care Advisory Board
2001 - Present The American Journal of Hospice and Palliative Care, Editorial Board, Member
2002 ACGME Fellowship in Pain Management Curriculum Committee, member
2002 Ad Hoc reviewer for Anesthesia and Analgesia, Mayo Clinic Proceedings, The Medical Letter
2002-2003 For mention in Marquis Who¡¦s Who in Medicine and Healthcare, 4th Edition
2002 - Present Pain Medicine, Journal of Terminal Oncology, Practical Pain Management, The Journal of Neuropathic Pain and Symptom Palliation, Editorial Board, Member
2001- 2003 ABMS Pain Management Board Examination, Item Writer, Questions Author
2001-2002 NIH Pain and Palliative Care Advisory Board, Member
2001 Visiting Professor,
2001 For mention in Consumers¡¦ Guide to Top Doctors, Center for the Study of Services, Washington, DC,
2003
2003
2004
2005 Chair, Ad Hoc Committee on Appointments and Promotions,
2005 Pappagallo M (Editor). The Neurological Basis of Pain, McGraw-Hill Professional,
2005 American Pain Society Clinical Practice Guidelines Panel on Low Back Pain, Member
2005 For mention in Marquis Who ¡s Who in
2005 Palliative Medicine Textbook (Eds Twycross RG, Davis MP, Dickerson D, Shuster J, Pappagallo M) hhtp://wwwpmph.com, Chinese language; pp 794;
2004-2005 ABA-ABMS Pain Management Board Examination, Item Writer, Questions Author
2005 Physician of the Year Award ¡V Annual Ceremony Bikur Cholim Mazkereth Frima D’Munkakacs.
GRANT SUPPORT RESEARCH PROJECTS THAT CONTRIBUTE TO THE CARE OF PATIENTS
1994 - 1999 National Institutes of Health PO1 NS 32386-01; Co-PI (with Dr SN Raja) in project 4; 20% time; $220,000/yr. A randomized, double blind, placebo-controlled, crossover clinical trial to determine the efficacy of tricyclics (nortriptyline, desipramine) and long-acting oral opioids (controlled-release morphine, methadone) in the treatment of post-herpetic neuralgia.
1997 - 1999 Ortho-McNeal - RPN #97-08-18-04; PI: Pappagallo M; 10%; $45,000; A pilot study of topiramate in the treatment of postherpetic neuralgia. Dr. Pappagallo - initiated grant.
1997 - 1999 National Institutes of Health PO1 HD33990; Co-PI (with Dr SN Raja) in project 2; 10%; 200,000/yr. Pain management in persons with physical disability: a randomized, double-blind, placebo-controlled, crossover clinical trial to determine the efficacy of mexiletine and controlled-release oral morphine in the treatment of post-amputation pain and phantom pain.
1998 - 1999 Blaustein Research Funds - RPN #96-12-19-01; PI: Pappagallo M; 10%; $25,000; Treatment trial of high concentration capsaicin for chronic intractable neuropathic pain and hyperalgesia (
1998 - 1999 Glaxo- RPN #97-03-28-01; PI: Pappagallo M; 10%; $65,000; Imaging neurogenic inflammation in migraine patients. Dr. Pappagallo - initiated grant.
1998 - 1999 Pfizer - RPN # 98-07-14-03; PI: Pappagallo M; 10% time; $60,000. Phase II double blind, placebo-controlled, parallel 4-week evaluation of the efficacy and safety of multiple doses of CJ-13, 974 (opioid kappa agonist) in subjects with moderate to severe chronic low back pain. Multi-center study.
2000 - 2001 National Institutes of Health ¡VRPN # 00-CC-0086; Co-Investigator in NIH-intramural study: Dynamic contrast enhanced MR imaging of the meninges during a nitroglycerin-provoked migraine headache. (PI: Dr Bruce Wasserman).
2002- 2003 Pfizer; PI: Pappagallo M; 5%; $88,000. Does Treatment Of Elderly Patients With Donezepil Lower The Risk Of Postoperative Confusion And Delirium? Dr Pappagallo - initiated grant.
2002 - 2003 Elan; PI: Pappagallo M; 10%; $103,000. The Effect of Botulinum B Toxin on Neuropathic Pain from Median Nerve Entrapment Neuropathy; a Pilot Study in Patients with Carpal Tunnel Syndrome. Dr Pappagallo - initiated grant
2003 - 2005 Glaxo-SK; PI: Pappagallo M; 5%; $179,193. A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Trial Of Lamotrigine For Central Pain Due To Multiple Sclerosis: A Model For The Role Of Lamotrigine In The Treatment Of Central Pain. Dr Pappagallo - initiated grant.
2003 - 2005 Endo Pharmaceuticals; Co-PI; 1%. $57,000; Pain Medicine Specialists, Their Number, Location, and Training. Dr Breuer - initiated grant.
2003- 2006 National Institutes of Health - National Institute of Neurological Disorders and Stroke; RO1¡VNS044845; PI: Pappagallo M; 25%; $1.7M grant support; 8/1/03-7/31/06; A pilot trial of intravenous pamidronate for chronic low back pain. Principal Investigator - Dr Pappagallo.
2005 - 2006 Roche Pharmaceutical; PI: Pappagallo M; 10%; $253,500. An open label Pilot Trial of IV Ibandronate for Complex Regional Pain Syndrome. 2/15/05-4/30/06 Investigator - Dr Pappagallo initiated grant.
Proposals Submitted & Pending Review
2005 National Institutes of Health - National
2005 Alzheimer’s Association; Co- PI; 5 %; (with Dr Brenda Breuer) ($200,000; funding decision due in July 2005) Pilot Trial: audio/Visual Pain Teleconsultations for Elderly with Dementia.
2005 Retirement Research Foundation. Co- PI; 5 % (with Dr Brenda Breuer) Audio/Visual Pain Teleconsultations for Elderly Nursing Home Residents: A Pilot Study ($255,000; funding decision due in Sept 2005). Dr Pappagallo initiated grant.
Selected Publications
INVITED LECTURES and CME accredited COURSES
1991 Rheumatology Grand Round, "Sympathetically Maintained vs. Sympathetically Independent Pain Syndromes,"
BIBLIOGRAPHY
Peer-Reviewed Articles and Original Communications
1. Pappagallo M, Gaspardone A, Tomai F, Iamele M, Crea F, and Gioffre¡¦ PA. Analgesic Effect of Bamiphylline on Pain Induced by Intradermal Injection of Adenosine. Pain, 53:199-204, 1993.
2. Pappagallo M, Raja SN, Haythornthwaite JA, Clark M, and
3. Pappagallo M and Campbell JN. Chronic Opioid Therapy as Alternative Treatment for Post-Herpetic Neuralgia. Annals of Neurology, 35:S54-56, 1994.
4. Gaspardone A, Crea F, Tomai F, Iamele M, Pappagallo M, Versaci F, Crossman DC, Chiarello L, Gioffre' PA. Substance P Potentiates the Algogenic Effects of the Intra-Arterial Infusion of Adenosine. Journal of
5.
6.
7. Pappagallo M and Heinberg LJ. Ethical Issues in the Management of Chronic Non-Malignant Pain. Seminars in Neurology. 17:3, pp 203-211, 1997. 8. Lavin RA, Pappagallo M, and Kuhlemeier KV. Cervical Pain: a Comparison of Three Pillows. Archives of Physical Medicine and Rehabilitation. 78 (2): 193-198, 1997.
9. Robbins WR, Staats PS, Levine J, Fields HL, Allen RW,
10. Haythornthwaite JA, Menefee LA, Quatrano-Piacentini
11. Pappagallo M. The Concept of Pseudotolerance. J Pharm Care Pain Sympt Control. 6(2): 95-98, 1998.
12. Pappagallo M. An Apparent Interventional Paradox: The Stimulation of the Motor Cortex, a New and Promising Treatment for Intractable Neuropathic Pain. In: Neurology Network. Vol 3, No 6, pp305-8.Dec 1999.
13. Fuchs PN, Pappagallo M, and Meyer RA. Topical EMLA Pre-Treatment Fails to Decrease the Pain Induced by 1% Topical Capsaicin. Pain. Apr. 80 (3): 637-42, 1999.
14. Clark MR, Heinberg LJ, Haythornthwaite JA, Quatrano-Piacentini
15. Pappagallo M, Oaklander AL, Quatrano-Piacentini
16. Pappagallo M. Dickerson ED, Hulka S. Palliative Care and Hospice Opioid Dosing Guideline. Am J Hosp Palliat Care Vol.17, No.6, Nov/Dec; 2000.
17. Dickerson ED, Davis M. Pappagallo M., Benedetti C.,
18. Davis MP, Dickerson ED, Pappagallo M, Varga J, Shuster, Jr. J, Benedetti C. Palliative Care: Long-Term Solution for Long-Term Care Part 1. Home Care Provid, 2001 Jun; 6(3): 91-7.
19. Davis MP, Dickerson ED, Pappagallo M, Varga J, Shuster J Jr, Benedetti C. Palliative care: A long-term solution for long-term care Part 3: Analgesic therapy (CE). Home Care Provid 2001 Oct; 6(5): 164-70
20. Pappagallo M, Snow B. Pain Medicine and Psychophysics in Journal of Pain and Symptom Management. Vol. 20. No, 6. Dec. 2000.
21. Pappagallo M, Rosenberg A, Epidemiology, Pathophysiology, and Management of Complex Regional Pain Syndrome Pain Practice. Vol 1, No 1; pp 11-20; 2001
22. Cox J, Pappagallo M. Contemporary and Emergent Pharmacological Therapies for Chronic Disabling pain Syndromes: Focus on Non-Opioid Analgesia. Expert Rev. Neurotherapeutics. 1(1), 81; 2001
23. Cox JM, Pappagallo M. Modafanil: A Gift to Portmanteau. Am J Hosp Palliat Care. Nov-Dec; 18(6): 408-10; 2001
24. Pappagallo M. Incidence, Prevalence, and Management of Opioid Bowel Dysfunction. The American Journal of Surgery 182; 11S-18S; Nov 2001. 25. Haldey EJ, Pappagallo M. Cardiovascular Events and COX-2 Inhibitors. JAMA. 2001 Dec 12; 286(22): 2808-2813.
26. Pappagallo M, Dickerson ED, Twycross R. Low doses of opioid antagonists enhance morphine analgesia and reduce adverse effects. In: Progress in Palliative Care. Vol 9; 5:194-5. 2001
27. J Cox, Pappagallo M, Pharmacological approach to neuropathic pain: balancing efficacy, safety, and tolerability. In Pain Management Today (McCarberg and Turk Eds). Vol. 2, No. 1, pp1-10. 2002
28. Fine PG, Pappagallo M, Price DD. Clinical advances in pain management: enhanced analgesia through NMDA receptor modulation. In American Journal of Pain Management. Vol 12, No 4, pp1-8S. Oct 2002.
29. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison, TG, Sabeen S, Royal RM, Max MB, Opioids versus antidepressants in postherpetic neuralgia: A randomized placebo-controlled trial; Neurology, 2002; 59:1015-1021
30. Mastronardi L, Pappagallo M, Puzzilli F, Tatta C, Efficacy of the morphine-ADCON-L compound in the management of postoperative pain after lumbar microdiscectomy. Neurosurgery. 2002 Mar; 50(3): 518-24
31. Haythornthwaite JA, Clark M, Pappagallo M, Raja SN, Pain Coping Strategies Play a Role in the Persistence of Pain in Post-Herpetic Neuralgia, Pain. 2003 Dec; 106(3): 453-60.
32. Pappagallo M, Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine. Clin Ther. 2003 Oct; 25(10): 2506-38. Review.
33. Pappagallo M, Haldey EJ: Pharmacological Management of Postherpetic Neuralgia. CNS Drugs 2003; 17(11): 771-780.
34. Pappagallo M, Breuer B, Schneider A, Sperber K, Treatment of Chronic Mechanical Spinal Pain with Intravenous Pamidronate. J Pain and Symptom Manage. Vol. 26:678-683. July, 2003
35. Lussier D, Pappagallo M, 10 most commonly asked questions about the use of opioids for chronic pain. The Neurologist. Vol 10, Number 4, pp 1-4, July 2004
36. Pappagallo M,
37. Bennett D, Burton AW, Fishman S, Fortner B, McCarberg B, Miaskowski C, Nash D, Pappagallo M, Payne R, Viscusi E, Wong W. Consensus Recommendations for the Assessment and management of Breakthrough Pain.
38. Bennett D, Burton AW, Fishman S, Fortner B, McCarberg B, Miaskowski C, Nash D, Pappagallo M, Payne R, Viscusi E, Wong W. Consensus Recommendations for the assessment and management of breakthrough pain. Part II. Pharmacy and Therapeutics. 2005 (in press).
39. Breuer B, Sperber K, Wallenstein S, Kiprovski K, Calapa A, Snow B, Pappagallo M: Clinically significant placebo analgesic response in a pilot trial of Botulinum B in patients with hand pain and carpal tunnel syndrome. Pain Medicine 2005 (in press). 40. Breuer B, Goldfarb R, Ongseng F, Pappagallo M: What is the Association between Low Back Pain and Signs of Abnormal Bone Activity Detected by Bone Scans? 2005 (submitted to European Spine Journal)
Educational Material Chapters in Books
41. Pappagallo M. Painful Neuropathies, In: Current Therapy in Neurological Diseases-4, Johnson RT (ed.), Mosby-Yearbook, 1993.
42. Pappagallo M. Analgesics. Biomechanics. Vol.2, 7:26-30, 1995.
43. Pappagallo M. Controlled Clinical Trial to Test Opioids in Neuropathic Pain. Neuroscience Forum. Vol. 5, 1:10-13, 1995.
44. Pappagallo M and Campbell JN. The Pharmacologic Management of Chronic Back Pain. In: The Adult Spine: Principle and Practice, Raven Press, 2nd edition. Frymoyer JW, Editor-in-chief. pp 275-286, 1997.
45. Pappagallo M and Campbell JN. The Medical Treatment of Chronic Back Pain: The Role of Opioid Therapy and the Use of Nonopioid Analgesics, In: Spine: State of the Art Reviews. Kostuik JP (ed). pp 1-13, Hanley & Belfus, Inc.,
46. Pappagallo M. Commentary on: Migraine Associated with Head Trauma, by Russell MB and Olsen J. The Pain Medicine Journal Club Journal, Vol 3, No 2, pp 66-68, 1997.
47. Pappagallo M. Water Pillow Softens Pain in the Neck. Modern Medicine, 65:5, pp 26, 1997.
48. Pappagallo M. Commentary on: Intravenous Guanethidine in Patients with Reflex Sympathetic Dystrophy by Kaplan R, et al. The Pain Medicine Journal Club Journal, Vol 3, No 6, 278-280, 1997.
49. Williams VB, Pappagallo M. Entrapment Neuropathies. In: Essentials of Pain Medicine. Raja SN, Benson HT (Eds).
50. Williams V, Pappagallo M. Central Pain. In: Essentials of Pain Medicine. Raja SN, Benson HT (Eds).
52. Pappagallo M. Commentary on: Complex Regional Pain Syndrome Type I (RSD): Pathology of Skeletal Muscle and Peripheral Nerve by van der Laan, L. et al. The Pain Medicine Journal Club Journal, Vol 4, No. 5, 184-185, 1998.
53. Campbell JN, Pappagallo M, Robbins W, and Staats P. Capsaicin revisited as a treatment for neuropathic pain. In: Novel Targets in the Treatment of Pain. IBC Publishers,
54. Pappagallo M. Aggressive Pharmacologic Treatment of Pain. In: Rheumatic Disease Clinics of
55. Pappagallo M. The Pain in Migraine is Not Mainly in the Brain. In: Johns
56. Pappagallo M. Inside Answers on Migraine. In: The Johns
57. Pappagallo M. Complex Regional Pain Syndromes. In Management of Neuropathic Pain Syndromes: Supplement to Neurology Reviews. March 2000.
58. Pappagallo M. The Diagnosis and Management of Neuropathic Pain. In: Handbook of Pain Management (3rd Edition) Tollison CD Ed. Dec. 2001
59. Davis MP, Dickerson ED, Pappagallo M, Varga J, Shuster J Jr, Benedetti C. Palliative care: Long-term solution for long-term care Part 2: Types of pain: A review (CE). Home Care Provid, 2001 Aug; 6(4): 126-33.
60. Pappagallo M, Dickerson Ed, Varga J, Cox JM, Benedetti C, Davis M. Management of Neuropathic Pain in Palliative Practices from A ¡V Z for the Bedside Clinician (Kuebler KK and Esper P Eds) Oncology Nursing Society, Pittsburgh. Pp 247-253. 2002
61. Pappagallo M, Dickerson Ed, Varga J, Cox JM, Benedetti C, Davis M, Esper P. Pain in Palliative Practices from A ¡V Z for the Bedside Clinician (Kuebler KK and Esper P Eds) Oncology Nursing Society, Pittsburgh. Pp 185-192. 2002
62. Pappagallo M, The clinical expert: controversies in neuropathic pain, Summer 2002, Vol. II, No 2, pp 1-8, by www.emergingsolutionsinpain.com, MediCom Worldwide, Inc 2002
63. Pappagallo M, (Editor), The Neurological Basis of Pain, McGraw-Hill Professional,
64. Pappagallo M, Peripheral Neuropathic Pain. In: The Neurological basis of Pain; Chapter 23 (Pappagallo M. Editor). McGraw-Hill Professional,
65. Knotkova H, Pappagallo M, Pharmacology of Pain Transmission and Modulation. In: The Neurological Basis of Pain; Chapter 3 (Pappagallo M. Editor). McGraw-Hill Professional,
66. Chun-Su Yuan, Pappagallo M. Introduction. In: Opioid Bowel Dysfunction (Ed. by Chun-Su Yuan). Approx. 290 pp. with Index. The Haworth Press, Inc. In Press. Fall 2005
67. Ysmael Yap, Pappagallo M. The Epidemiology of Opioid Bowel Dysfunction. Chapter 4. In: Opioid Bowel Dysfunction (Ed. by Chun-Su Yuan). Approx. 290 pp. with Index. The Haworth Press, Inc. In Press. Fall 2005
68. Stern M, Sperber K, Pappagallo M. Tramadol. Chapter 14, Section IV. In: Pain Medicine & Management: Just the facts ((Eds: Wallace MS, Staats PS). McGraw-Hill.
69. Pappagallo M. Difficult Pain Syndromes: Bone Pain, Visceral Pain, Neuropathic Pain. For The 3rd Edition of Principles and Practice of Palliative Care and Supportive Oncology (Eds: Berger AM, Von Roenn JH, Shuster JL). In Preparation. 2005
70. Pappagallo M. Adjuvants for pain. For: Pain and Chemical Dependency, (Eds: Howard Smith and Steven Passik), to be published by Oxford University Press, in preparation, 2005.
PATENTS
1999 U.S. Patent No. 5,962,532 issued on 10/5/99 and licensed; Therapeutic Method with Capsaicin and Capsaicin Analogues - Inventors: Campbell JN, Pappagallo M, and Meyer R.
2001 U.S. Patent No. 6,248,788 issued on 6/19/01 and licensed; Therapeutic Method with Capsaicin and Capsaicin Analogues ¡V Inventors: Robbins W, Staats P, and Pappagallo M.
2003
2003
2005 U.S. Patent Application No: 10/496,451 (projected publication date July 7, 2005). Management of Postoperative Pain ¡V Inventors: Pappagallo M, Mastronardi L